NVO vs. ORCL
NVO (Novo Nordisk A/S) and ORCL (Oracle Corporation) are both stocks. NVO operates in Drug Manufacturers - General (Healthcare), while ORCL operates in Software - Infrastructure (Technology). Over the past 10 years, NVO returned 8.18%/yr vs 13.12%/yr for ORCL. At a 0.19 correlation, their price movements are largely independent.
Performance
NVO vs. ORCL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NVO achieves a 0.91% return, which is significantly higher than ORCL's -37.12% return. Over the past 10 years, NVO has underperformed ORCL with an annualized return of 8.18%, while ORCL has yielded a comparatively higher 13.12% annualized return.
NVO
- 1D
- -1.41%
- 1M
- 14.86%
- 6M
- -17.63%
- YTD
- 0.91%
- 1Y
- -19.26%
- 3Y*
- -13.51%
- 5Y*
- 4.43%
- 10Y*
- 8.18%
- ALL TIME*
- 14.52%
ORCL
- 1D
- -3.98%
- 1M
- -33.91%
- 6M
- -36.04%
- YTD
- -37.12%
- 1Y
- -49.98%
- 3Y*
- 2.24%
- 5Y*
- 7.68%
- 10Y*
- 13.12%
- ALL TIME*
- 21.29%
NVO vs. ORCL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | 0.91% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
ORCL Oracle Corporation | -37.12% | 18.13% | 59.99% | 30.94% | -4.65% | 36.89% | 24.25% | 19.34% | -2.97% | 24.94% |
Correlation
The correlation between NVO and ORCL is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Mar 12, 1986 | 0.19 |
Fundamentals
NVO:
$220.46B
ORCL:
$349.60B
NVO:
DKK 27.42
ORCL:
$5.86
NVO:
11.83
ORCL:
20.71
NVO:
0.51
ORCL:
0.85
NVO:
4.40
ORCL:
5.25
NVO:
7.11
ORCL:
8.22
NVO:
DKK 327.80B
ORCL:
$67.36B
NVO:
DKK 268.30B
ORCL:
$79.58B
NVO:
DKK 181.54B
ORCL:
$6.20B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVO vs. ORCL — Risk / Return Rank
NVO
ORCL
NVO vs. ORCL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NVO) and Oracle Corporation (ORCL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NVO | ORCL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.39 | ||
| Sortino ratioReturn per unit of downside risk | +1.04 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 0.87 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | -0.39 | -0.80 | +0.41 |
| Martin ratioReturn relative to average drawdown | -0.61 | -1.28 | +0.67 |
Loading charts...
Drawdowns
NVO vs. ORCL - Drawdown Comparison
The maximum NVO drawdown since its inception was -74.70%, smaller than the maximum ORCL drawdown of -84.19%. Use the drawdown chart below to compare losses from any high point for NVO and ORCL.
Loading charts...
Drawdown Indicators
| NVO | ORCL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.70% | -84.19% | +9.49% |
Max Drawdown (1Y)Largest decline over 1 year | -49.17% | -62.61% | +13.44% |
Max Drawdown (3Y)Largest decline over 3 years | -74.70% | -62.61% | -12.09% |
Max Drawdown (5Y)Largest decline over 5 years | -74.70% | -62.61% | -12.09% |
Max Drawdown (10Y)Largest decline over 10 years | -74.70% | -62.61% | -12.09% |
Current DrawdownCurrent decline from peak | -63.95% | -62.61% | -1.34% |
Average DrawdownAverage peak-to-trough decline | -17.89% | -29.16% | +11.27% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 31.75% | 39.16% | -7.41% |
Volatility
NVO vs. ORCL - Volatility Comparison
The current volatility for Novo Nordisk A/S (NVO) is 9.48%, while Oracle Corporation (ORCL) has a volatility of 13.67%. This indicates that NVO experiences smaller price fluctuations and is considered to be less risky than ORCL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVO | ORCL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.48% | 13.67% | -4.19% |
Volatility (6M)Calculated over the trailing 6-month period | 37.43% | 42.95% | -5.52% |
Volatility (1Y)Calculated over the trailing 1-year period | 51.79% | 65.37% | -13.58% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.58% | 42.65% | -4.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.63% | 35.47% | -2.84% |
Dividends
NVO vs. ORCL - Dividend Comparison
NVO's dividend yield for the trailing twelve months is around 3.63%, more than ORCL's 1.65% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | 3.63% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
ORCL Oracle Corporation | 1.65% | 0.97% | 0.96% | 1.44% | 1.57% | 1.38% | 1.48% | 1.72% | 1.68% | 1.52% | 1.56% | 1.56% |
Financials
NVO vs. ORCL - Financials Comparison
This section allows you to compare key financial metrics between Novo Nordisk A/S and Oracle Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NVO and ORCL have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ORCL has higher volatility (13.67%) compared to NVO (9.48%). In terms of maximum drawdown, NVO dropped -74.70% vs ORCL's -84.19%.
NVO currently has the higher Sharpe Ratio (-0.37 vs -0.77), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NVO and ORCL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer